30

nanotimes

Companies Facts

Infineon’s revenues in the first quarter of the 2011 fiscal year were Euro922 million, down two percent compared to the fourth quarter of the 2010 fiscal year.

http://www.infineon.com/USB3.0protection http://www.infineon.com/sensors

I

tN Nanovation AG (ISIN: DE000A0JL461), Germany has announced the signing of a conditional equity

investment agreement of up to EUR15 million with YA Global Master SPV Ltd., which is managed by Yorkville Advisors, LLC, a large U.S.-based invest- ment group.

Under the agreement, ItN Nanovation has the right to issue new shares to YA Global in one or more tranches over the next three years for a total amount of up to EUR15 million, thereby ensuring that it has a strong equity capital base to support its ongoing growth.

ItN Nanovation retains full discretion as to whether, and to what extent, it exercises these rights. The agreement thus provides the company with a high degree of flexibility in its financial planning, enabling it to capitalize on growth opportunities as they arise. http://www.itn-nanovation.de

manufacturer with low-cost operations based in Chi- na, has entered into a commercial agreement with Innovalight, Inc., a privately-held company based in Sunnyvale, California, that manufactures proprietary silicon ink and licenses proprietary processing tech-

J

inkoSolar Holding Co., Ltd. (NYSE: JKS), a fast-growing vertically integrated solar product

nology to solar cell manufacturing companies. Under the terms of the agreement, JinkoSolar will purchase silicon ink from Innovalight and license Innovalight‘s processing technology to produce solar cells with higher conversion efficiencies.

“JinkoSolar‘s strong brand presence across a broad geographic network makes the company an impor- tant customer for us,” added Conrad Burke, Chief Executive Officer at Innovalight. “Our silicon ink technology, in combination with JinkoSolar‘s leading vertically integrated manufacturing platform, will offer an attractive and highly powerful solar product. We look forward to working with JinkoSolar as we partner to bring a progressive technology and impro- ved solar product to the market.”

Innovalight‘s proprietary nanotechnology-based silicon ink and processing platform provide a simple upgrade to solar cell manufacturing production lines that boosts the performance of solar cells and lo- wers production costs. With Innovalight technology, JinkoSolar expects to produce monocrystalline solar cells with conversion efficiencies greater than 18.6% in the first half of 2011. http://www.innovalight.com http://www.jinkosolar.com

K

INAXO Biotechnologies GmbH has entered into a collaboration with AstraZeneca. Under the terms

of the agreement, KINAXO will apply its technology platform to support one of AstraZeneca’s oncolo- gy programs. KINAXO will employ high-end mass spectrometry-based technologies to quantitatively analyze posttranslational protein modifications on a proteome-wide scale. Since protein modifications play pivotal roles in many cellular processes (e.g. cell

11-01 :: December 2010 / January 2011